Author:
Bohlmann Michael K.,Hornemann A.,Sänger N.,Hackethal A.,von Horn K.,Wilkens P.S.,Hoellen F.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Reproductive Medicine,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health
Reference42 articles.
1. Brandon DD, Bethea CL, Strawn EY et al (1993) Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. Am J Obstet Gynecol 169:78–85
2. Brito LG, Candido-dos-Reis FJ, Magario FA, Sabino-de-Freitas MM (2012) Effect of the aromatase inhibitor anastrozole on uterine and leiomyoma Doppler blood flow in patients scheduled for hysterectomy: a pilot study. Ultrasound Obstet Gynecol 40:119–120
3. Britten JL, Malik M, Levy G, Mendoza M, Catherino WH (2012) Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production. Fertil Steril 98:1299–1307
4. Carr BR, Marshburn PB, Weatherall PT et al (1993) An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial. J Clin Endocrinol Metab 76:1217–1223
5. Chang WC, Chu LH, Huang PS, Huang SC, Sheu BC (2015) Comparison of laparoscopic myomectomy in large myomas with and without leuprolide acetate. J Minim Invasive Gynecol (im Druck). DOI 10.1016/j.jmig.2015.04.026